AMICUS THERAPEUTICS, INC. - Common Stock (FOLD)

CUSIP: 03152W109

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock
Shares outstanding
312,579,912
Total 13F shares
320,821,396
Share change
+3,233,518
Total reported value
$4,566,415,455
Put/Call ratio
186%
Price per share
$14.24
Number of holders
328
Value change
+$318,210,379
Number of buys
194
Number of sells
130

Quarterly Holders Quick Answers

What is CUSIP 03152W109?
CUSIP 03152W109 identifies FOLD - AMICUS THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q4 2025

As of 31 Dec 2025, AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by 328 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 320,821,396 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, HBK INVESTMENTS L P, STATE STREET CORP, Pentwater Capital Management LP, Bellevue Group AG, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, PERCEPTIVE ADVISORS LLC, and GOLDMAN SACHS GROUP INC. This page lists 328 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.